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The presence ofreceptors specific for the Fc fragment of IgG (FcyR)' on monocytes
and macrophages (MO) is well established (1-4) . Recently, mouse MO or macrophage-
like cell lines were shown to have two FcyR, one being trypsin sensitive and binding
monomeric or aggregated mouse IgG2a . The other is trypsin resistant and binds
aggregated or immune-complexed mouse IgGI and IgG2b (5, 6) . Unkeless (7, 8)
provided additional evidence for the presence of two types of FcyR on mouse MO by
demonstrating a mutant mouse Mo line that binds IgG2a but not aggregated IgGI
and IgG2 . Anderson and Grey (9) noted that the detergent-solubilized FcyR for
IgG2a is phospholipase C sensitive, whereas the solubilized FcyR for aggregated IgG
is not . Furthermore, Lane et al . (10) obtained structural evidence for the presence of
two FcyR on mouse peritoneal macrophages (PMO) . They showed that a trypsin-
sensitive peptide of 67,000 mol wt binds IgG2a, whereas a trypsin-resistant 52,000
mol wt peptide binds IgG' and IgG2b . Guinea pig PMO also seems to have two FcyR :
one for IgGI and one for IgG2 (11) .
Rat Mo were shown to form rosettes with rabbit IgG- (12) and rat IgE-coated (13)
erythrocytes and to bind aggregated radiolabeled IgE (14), demonstrating that they
bear FcR for IgG and IgE (FceR) . However, the specificity ofFcyR for different IgG
subclasses on rat Mo is unknown, and little is known ofFcR for Ig classes other than
IgE and IgE . Therefore, we investigated the ability of rat alveolar macrophages
(AMO) and PMO to form rosettes with fixed ox erythrocytes (Eo~ coated with rat
myeloma proteins of all five rat Ig classes and of the four IgG subclasses . Evidence
will be presented demonstrating that rat M(A have an FcR for rat IgG2a, an FcR for
IgG1 and IgG2b, and an FcR for IgE .
Materials and Methods
Animals. Lewis and Brown Norway rats weighing 200-300 g were obtained from the
breeding colony of the Scripps Clinic and Research Foundation, La Jolla, Calif.
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'Abbreviations used in thispaper:
￿
AMO, alveolar macrophage ; DNP, dinitrophenyl ; Eb, burro erythrocyte ;
Eo, fresh ox erythrocyte ; Eo', fixed ox erythrocyte ; EoAy, EoA,u, EoAyI, EoAy2, EoAa, fresh ox erythrocytes
sensitized with rabbit IgG, rabbit IgM, rat IgGI and rat IgG2 anti-Eo antibodies, and mouse IgA anti-
DNP MOPC315 myeloma protein, respectively; FcR, FcyR, FoER, Fc receptor, FcR for IgG and IgE,
respectively; M0, macrophage ; MEM, minimum essential medium ; PMO, peritoneal macrophage; SDS-
PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis ; SRS-A, slow-reacting substances of
anaphylaxis .
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Macrophages. Rat AMO were obtained by bronchial lavage with Hanks' balanced salt
solution containing 0.25% EDTA and 2.5% fetal calf serum (FCS; 15). PM(A were harvested 4
d after proteose-peptone stimulation by rinsing the peritoneal cavities, as previously described
(15) . The Mo were then purified by adherence to plastic petri dishes (13) . Over 95% of the
recovered adherent cells consisted of MO, as judged by morphologic criteria after Wright
staining of cytocentrifuge preparations or nonspecific esterase staining (16), and by the ability
to phagocytose latexparticles (15) . HumanU937 (17) andmurine P388D1 (18) macrophagelike
cell lines were cultured in RPMI-1640medium supplemented with 10%FCS, 2 mM glutamine,
100 U/ml penicillin, and 100 jig/ml streptomycin (Flow Laboratories, Inc., Rockville, Md.) .
The viability of the cultured cells was 92-98%, as determined by trypan blue dye exclusion.
Myeloma Proteins.
￿
Rat myeloma proteins were isolated from the sera or ascitic fluids of Lou/
M/Wsl rats bearing the corresponding immunocytomas, as previously described (19, 20). They
included IgG1 (IR10, IR27, and IR595), IgG2a (IR33, IR418, and IR530), IgG2b (IR863),
IgG2c (IR304), IgA (IR22), IgD (IR731), IgE (IR2, IR162), and IgM (IR473). The purity of
these isolated myeloma proteins was evaluated by immunoelectrophoresis and Ouchterlony
analysis with class and subclass specific antisera and by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) . To remove aggregates, isolated immunoglobulins were ultra-
centrifuged for 90 min at 100,000 g in a Beckman SW50.1 rotor (Beckman Instruments, Inc.,
Fullerton, Calif.) and separated into three fractions. The upper third of the supernatant fluid
was used immediately for coating Eo' and for inhibition studies. IgG was heat aggregated at
63°C for 30 min at a concentration of 10-20 mg/ml in phosphate-buffered saline (PBS ; 21).
IgE was heat denaturedby incubation in a56°C water bath for 3h. Human myeloma proteins
of different Ig classes and subclasses were isolated as previously described (22) . Purified mouse
IgG and IgA myeloma proteins were purchased from Bionetics Laboratory Products, Litton
Bionetics, Kensington, Md.
Immunoglobulins. Rat anti-ox erythrocyte (Eo) antibodies were raised by subcutaneous
biweekly injections of 0.5 ml of 10% Eo in complete Freund's adjuvant . Rat IgG anti-Eo
antibodies were isolated by acombination of ammonium sulfate fractionation at 40% saturation
and stepwise DEAE-cellulose chromatography using 0.005 M phosphate buffer, pH 8.0, for
elution of IgG2, and 0.05 M of thesame buffer forelution of IgGl . Normal rat IgG and rabbit
IgG were isolated from normal sera with 0.005 M buffer. Rabbit IgG and IgM anti-Eo
antibodies were purchased from N. L. Cappel Laboratories Inc., Cochranville, Pa. Antisera to
rat IgG subclasses were purchased from Miles Laboratories, Inc., Elkhart, Ind.
Rosette Assays.
￿
Two types of indicator cells were prepared and used in a rosette assay to
detect FcRon M4). For the first, Eo wastrypsinized, washed, andtreated with pyruvicaldehyde
and formaldehyde (23) . These Eo' were then coated with myeloma proteins or normal IgG. Ig
in amounts ranging from 0.01 to 1.0 mg/ml Eo' were tested for the most effective coatingof the
Eo'; usuallya final concentration of0.25 mg Ig/ml Eo'provided optimalEo'coating. Routinely,
50 ltl of 10% Eo' was washed twice with 0.1 M acetate buffer, pH 5.0, and suspended in 450
ltl of the same buffer. 50 ttl of a 2.5 mg/ml Ig was then added, and the cells were incubated on
a rotator for 2 h at room temperature, washed three times in PBS, and resuspended in 0.5 ml
PBS. To prepare the second type of indicator cells, washed, fresh Eo were sensitized with the
highest subagglutinating concentration of rabbit IgG (EoAy) or IgM (EoAtt) anti-Eo antibodies,
and rat IgG (EoAyl) or IgG2 (EoAy2) anti-Eo antibodies. Trinitrophenyl-conjugated burro
erythrocytes (Eb) were optimally sensitized with mouseIgAantidinitrophenyl myelomaprotein
MOPC315 (EbAa; 24), as described by Strober et al. (25). The rosette assay and rosette
inhibition procedures have been previously described (13) . To prevent phagocytosis of Eo' and
to reduce the percentage of spontaneously formed rosettes, all rosette assays were carried out at
4°C.
Trypsin and Neuraminidase Treatment.
￿
M(A at a concentration of 4 X 106 cells/ml PBS were
incubated for 20 min at 37°C with different concentrations oftrypsin [t.-(tosylamide-2-phenyl)-
ethyl-chloromethyl-ketone treated, 272 U/mg, 76% protein, Worthington Biochemical Corp.,
Freehold, N. J.]. An equivalent amount of soybeantrypsin inhibitor (Worthington Biochemical
Corp.) was then added and after brief incubation the cells were washed three times with cold
minimum essential medium (MEM) containing 2.5% FCS (MEM-2.5% FCS) . For rosette assays
they were resuspended at 4 X 106 cells/ml MEM-2.5% FCS.376
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Mtp suspended in MEM were incubated with 50 U/ml neuraminidase (Vibrio cholera,
Calbiochem-Behring Corp ., American Hoechst, San Diego, Calif), for 1 h at 37 °C . The cells
were then washed and suspended in MEM-2.5% FCS and used immediately for the rosette
assay.
Results
Rat Mo Forming Rosettes with Eo' Coated with Rat Myeloma Proteins and Heterologous
Ig . The percentage of rosettes formedby rat AMO with Eo' coated with rat myeloma
proteins of all classes and subclasses is shown in Table I . AMO formed rosettes with
Eo' coated with rat myeloma proteins of classes IgGl, IgG2a, IgG2b, and IgE . In
contrast, the percentage of rosettes formed with Eo' coated with rat IgG2c, IgA, IgM,
and IgD was similar to the percentage ofrosettes formed spontaneously with uncoated
Eo' . Eo' that were coated optimally with individual myeloma proteins within an Ig
class varied in their ability to form rosettes withAMO.
Of the heterologous Ig tested (Table I), human IgGl, IgG3, and IgG4, murine
TABLE I
Rat AMO Forming Rosettes with Eo' Coated with Ig of Different Classes and Subclasses
* Mean t SD of five to eight experiments .
TABLE II
AM¢ andPM¢ Forming Rosettes with Eo or Eb Sensitized with IgG, IgM,
and IgA Antibodies
* Mean t SD of three experiments .
$ Trinitrophenyl-conjugated Eb sensitized with the IgA mouse anti-DNP
myeloma protein MOPC315 .
Rat myeloma protein Percent rosettes* Heterologous Ig Percent rosettes*
None 6.4 t 3 .8 Human IgGl (Ben) 89 .9 t 5 .3
IgGI (IR595) 86 .2 ± 8 .8 Human IgG2 (Kel) 6 .6 t 3 .9
IgGl (IR10) 51 .4 t 7 .1 Human IgG3 (Fis) 90 .4 t 4 .8
IgGl (IR27) 58 .3 t 9 .5 Human IgG4 (Hof) 44 .6 t 17.9
IgG2a (IR33) 45 .1 ± 12 .3 Human IgE (Sha) 6 .3 f 3 .1
IgG2a (IR418) 38 .7 t 6 .5 Human IgAl (Pat) 7 .9 f 2 .7
IgG2a (IR530) 54 .7 t 9 .4 Human IgA2 (Kra) 5 .8 t 1 .3
IgG26 (IR863) 89.2 t 5 .1 Human IgM (Huf) 6 .9 ± 2 .3
IgG2c (IR304) 9.4 t 5 .3 Human IgD (Dil) 8 .1 t 2 .5
IgE (IR162) 84 .5 ± 5 .1 Mouse IgGI (MOPC21) 52 .7 ± 7 .7
IgE (IR2) 65 .2 f 13 .9 Mouse IgG2a (UPC10) 57 .4 t 7.9
IgM (IR473) 7.9 ± 4 .2 Mouse IgG26 (MOPC141) 26 .9 ± 8.1
IgA (IR22) 9 .2 ± 3 .8 Mouse IgG3 (1606) 6 .8 ± 2 .8
IgD (Ir731) 7 .1 ± 3 .3 Rabbit IgG (normal) 78 .7 t 8 .0
Indicator erythrocytes
Percent
AMO
rosettes*
PM0
Eo 01 . 10 .3 0 .2 f 0 .4
EoAyl (rat IgG1 anti-Eo) 85 .4 ± 6 .1 87 .5 ± 5 .4
EoAy2 (rat IgG2 anti-Eo) 88 .5 ± 4.2 88 .6 ± 4 .7
EoAy (rabbit IgG anti-Eo) 86 .1 ± 5 .9 87.7 ± 4 .5
EoAp (rabbit IgM anti-Eo) 0 .3 t 0.4 0.1 ± 0 .3
EbAa (mouse IgA anti-DNP)f 0 .2 t 0.5 0.3 ± 0 .6G. BOLTZ-NITULESCU, H. BAZIN, AND H. L. SPIEGELBERG
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IgG1, IgG2a, IgG2b, and rabbit IgG induced significant rosette formation, whereas
human IgG2, IgE, IgA, IgM, and IgD, and murine IgG3 did not.
MO Forming Rosettes with Antibody-sensitized Erythrocytes. To compare the results
obtained with Eo'coated with myeloma proteins with antibody-sensitized Eo, we used
rat IgG1 and IgG2, and rabbit IgG and IgM anti-Eo antibodies. In addition,
trinitrophenyl-conjugated Eb sensitized with the mouseIgAanti-dinitrophenyl (DNP)
myeloma protein MOPC315 were used to detect Fc receptors for IgA. As shown in
Table II, >80% of both AMO and PMO formed rosettes with Eo sensitized with rat
IgGI and IgG2 and with rabbit IgG antibodies. In contrast, AMO and PMO did not
form rosettes with rabbit IgM and mouse IgA-sensitized erythrocytes. Rat AMO and
PMO were cultured for up to 72 h in media free of rat serum or were treated with
neuraminidase to determine whether such treated MO form EoA/, or EbAa rosettes.
However, neither of these preparations formed rosettes with IgM or IgA antibody-
coated erythrocytes above background (data not shown) .
Ig Class and Subclass Specificity of Rosette Formation.
￿
The specificity of the rat MO
rosette formation was tested by inhibition with various rat myeloma proteins. As
shown in Fig. 1, IgGI and IgG2b rosettes were inhibited equally by IgGI, IgG2b, and
IgE. In contrast, IgG2a and IgE rosettes were inhibited only by IgG2a or IgE,
respectively. Rat IgG2c, IgA, IgM, and IgD did not inhibit IgGI, IgG2b, or IgE
rosettes even at the highest concentration (3 mg/ml) tested. Identical results were
obtained with Eo sensitized with rat IgGI or IgG2 antibodies; again, IgGI rosettes
were inhibited by IgGI, IgG2b, and IgE, whereas IgG2 rosettes were inhibited only
with IgG2a myeloma proteins (data not shown) .
Although IgE myeloma proteins inhibited IgGI/IgG2b rosettes on a milligram per
milliliter basis as much as did IgGI and IgG2b, the inhibition could have resulted
from trace contamination by normal IgG, particularly aggregated IgG. To eliminate
this possibility, we ultracentrifuged the IgE preparation and tested the top, middle,
and bottom fractions, the latter being expected to be enriched in IgG aggregates. In
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Inhibition of Eo'-IgGI (IR595), IgG2a (IR530), IgG2b (IR863), and IgE (IR162) rosettes
on rat AM¢ by rat myeloma protein IgGI (IR595), IgG2a (IR530), IgG2b (IR863), and IgE
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addition, we heated the IgE preparation at 56° C for 3 h, which destroys the ability
of IgE to bind to FCER (26) but does not affect IgG binding to FcyR (13) . As shown
in Table III, the ultracentrifuged IgE preparations, whether taken from the top or
bottom of the tube, inhibited equally the IgGl, IgG2b, and IgE rosettes, making it
very unlikely that IgG aggregates in the IgE preparations were responsible for the
inhibition. Furthermore, when the IgE was heated at 56°C, it lost its ability to inhibit
IgGl/IgG2b and IgE rosettes, again indicating that IgE, and not traces of contami-
nating IgG, was responsible for IgGI/IgG2b rosette inhibition.
To determine whether inhibition of IgG rosettes by IgE is a general phenomenon,
TABLE III
Inhibition ofIgG and IgE Rosette Formation on Rat AM(p by Ultracentrtfuged or Heated Rat IgE
* Mean ofthree experiments.
$ Ultracentrifuged at 100,000 g for 90 min and fractionated into three portions.
§ Heated for 3 h at 56°C and used immediately for inhibition at a final concentration of 3.0 mg/ml.
TABLE IV
Inhibition ofIgG and IgE Rosette Formation by Rat and Human IgE on Mouse and Human
Macrophagelike Cell Lines
Macrophage
cell line
Mouse P388D1
Human U937
* Mean f SD of three experiments.
$ Rat IgE (IR162) or human IgE (Sha) myeloma proteins at a final concentration of 1 .0 mg/ml.
§ (+) = percentage increase in rosette formation.
Indicator erythrocytes
Without
inhibitor
Percent rosettes*
With inhibitor$
Rat IgE
Percent
inhibition
Eo'-rat IgE (IR 162) 53.8 ± 12.4 1.3 ± 6.3 97.6
Eo'-rat IgG 1 (IR595) 78.9 ± 9.9 81.5 ± 6.0 (+3.3)§
Eo'-rat IgG2a (IR530) 43.1 ± 4.2 45.3 ± 3.9 (+5.1)
Eo'-rat IgG2b (IR863) 86.6 ± 5.2 88.7 ± 8.4 (+2.4)
Eo'-mouse IgGI (MOPC21) 46.3 ± 8.7 47.7 ± 7.6 (+3.0)
Eo'-mouse IgG2a (UPC10) 78.8 ± 5.7 81.5 ± 6.6 (+3.4)
Eo'-mouse IgG2b (MOPC141) 32.8 ± 5.8 35.5 ± 5.3 (+8.2)
EoAy (rabbit IgG) 90.6 ± 3.1 87.8 ± 6.3 3.1
Human IgE
Eo'-human IgE (Sha) 78.5 ± 5.7 7.3 ± 2.1 90.7
Eo'-human IgG1 (Ben) 80.5 ± 7.1 78.3 ± 8.9 2.7
Eo'-human IgG2 (Kel) 5.3 t 2.1 5.5 ± 3.3 (+3.8)
Eo'-human IgG3 (Fis) 81 .8 t 9.6 84.6 ± 11 .2 (+3.4)
Eo'-human IgG4 (Hol) 26.7 t 5.4 25.9 ± 6.1 3.0
EoAy (rabbit IgG) 90.3 t 5.5 86.6 ± 8.5 4.1
Percent rosette inhibition*
Inhibitor rat
IgE, 1 .0 mg/ml Eo'-IgGI
IR595 EoAyl
Eo'-
IgG2a
IR33
EoAy2
Eo'-
IgG2b
IR863
EoAy
Eo'-IgE
IR162
IR162 85.2 75.7 8.6 10.2 66.9 81 .6 86.6
IR162 top 'h$ 83.1 74.1 7.9 10.6 58.7 79.9 83.4
IR162 middle 1 /3 83.9 75.6 8.1 9.7 63.0 82.6 82.8
IR162 bottom '/3 86.7 78.1 9.5 12.6 65.8 83.9 87.1
IR162 A56§ 18.5 7.5 0.6 11 .5 0.2 7.2 10.1
IR2 78.2 72.1 6.8 14.1 61.7 63.1 82.4G. BOLTZ-NITULESCU, H. BAZIN, AND H. L. SPIEGELBERG
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TABLE V
Species Specificity of IgG Rosette Formation on Rat AMO
* The data represent the percentage of rosette inhibition (mean of three experiments) .
Not tested.
TABLE VI
Trypsin Sensitivity ofFc Receptors for IgG and IgE on Rat AMO
Percent rosette inhibition*
* Mean ofthree to four experiments. The data represent percentage decrease or increase (+) in the capacity
ofrat AMO to form rosettes after treatment with trypsin for 20 min at 37°C.
we inhibited IgG rosettes with IgE and IgG on mouse P388D1 and human U937
macrophagelike cell lines. As shown in Table IV, ^-50% of the mouse MO formed
rosettes with Eo' coated with rat IgE, and 80% of the human Mo formed rosettes with
Eo' coated with human IgE; both were inhibitable by >90% with the homologous
IgE. In contrast, neither rat nor human IgE inhibited IgG rosettes formed by different
rat, mouse, and human IgG subclasses, or those formed by rabbit IgG antibodies on
both mouse and human macrophagelike cell lines.
Species Specificity of IgG Rosettes on Rat Mo.
￿
To test the species specificity of the two
putative FcyR on rat Mq5, Eo' were coated with rat, human, and mouse IgG of
different subclasses or Eo were sensitized with rabbit IgG anti-Eo antibodies and used
in the rosette assay. As shown in Table V, rat IgGI and IgG2b rosettes were inhibited
by all IgG preparations tested, except rat IgG2a. Conversely, rat IgG2a rosettes were
inhibited only by rat IgG2a. IgG rosettes formed by Ed coated with human and
mouse IgG of different subclasses or by rabbit IgG antibodies were all inhibitable
with rat IgGI and IgG2b, heterologous IgG, and rat IgE but not with rat IgG2a.
Rosettes Formed by Trypsin-treated Mo.
￿
To determine the trypsin sensitivity of the
putative Fe receptors on rat Mo, the cells were incubated with various concentrations
of trypsin at 37 °C for 20 min, washed, and analyzed for rosette formation. As shown
Inhibitor, 1.0 mg/ml
Eo'-IgGI
IR595
Rat IgG
Eo'-W2a
IR530
Eo'-IgG26
IR863
Eo-IgGl
Ben
Human IgG
Eo'-IgG3
Fis
Eo'-IgG4
Hof
Mouse
Eo-WI
MOPC21
IgG
Eo'-IgG2a
UPC10
Rabbit
EoAy
Rat IgGI (IR595) 77.6 1.7 78.5 73.0 71.9 85.6 93.4 93.7 81.8
Rat IgG2a (IR530) 8.9 66.4 7.7 4.1 3.4 0.4 10.9 16.2 2.8
Rat IgG26 (IR863) 81.2 17.0 83.2 89.2 84.4 83.8 NTt NT 87.1
Rat IgE (IR162) 84.8 8.6 71.4 72.1 77.3 85.4 85.4 81.2 83.3
Human IgGI (Ben) 79.0 19.6 65.4 79.1 77.7 88.0 NT NT 82.9
Human IgG3 (Fis) 84.1 18.5 67.2 81.2 81.7 84.1 NT NT 87.6
Mouse IgGI (MOPC21) 68.2 3.1 NT NT 48.8 NT 85.3 88.9 NT
Mouse IgG2a (UPC10) 64.3 3.7 NT NT 53.9 NT 75.1 88.4 NT
Rabbit IgG (normal) 84.0 18.5 68.4 80.2 89.2 88.4 NT NT 73.9
Percent inhibition*
Trypsin Eo'-IgG 1
IR595 EoAyl
Eo'-IgG2a
IR530 EoAy2
Eo'-IgG2b
IR863 EoAy
Eo'-IgE
IR 162
mg/ml mg/ml
0.05 (+5.5) (+5.6) (+5.0) (+7.4) (+1.5) (+6.5) (+6.2)
0.1 10.0 9.3 (+13.4) (+5.3) (+4.7) 8.7 (+5.6)
0.5 51.1 28.4 (+5.5) (+2.8) 23.9 21.4 9.0
1 .0 83.2 50.6 16.3 5.2 48.7 40.5 43.5
5.0 96.9 84.3 26.1 18.7 77.6 71.8 82.1380
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in Table VI, trypsin treatment reduced IgGl, IgG2b, and IgE rosette formation by
up to 97%, whereas IgG2a rosette formation decreased only slightly, even at very high
trypsin concentrations. The decreased percentage of trypsin-treated AMO forming
rosettes with Eo sensitized with rabbit IgG anti-Eo antibodies offers further support
for the binding of heterologous IgG to the FcyR reacting with rat IgG1 and IgG2b.
Discussion
Rat MO were shown to form rosettes with Eo' coated with rat IgGI, IgG2a, IgG2b,
and IgE but not with rat IgM, IgA, IgD, and IgG2c myeloma proteins. The IgG2a
and IgE rosettes were inhibited only by IgG2a and IgE, respectively, whereas the
IgGI and IgG2b rosettes were equally inhibited by both IgGI and IgG2b myeloma
proteins. These findings indicate that rat Mo bear three types of Fc receptors: one
specific for IgG2a, one specific for IgE, and one reacting with both IgGI and IgG2b.
The IgG2a FcR was trypsin resistant, whereas the IgGl/IgG2b and the FcER were
trypsin sensitive. As shown by inhibition studies, heterologous IgG reacted with the
IgGI/IgG2b FcR but not with the IgG2a FcR. The rat Mo resemble mouse Mo that
also possess two FcyR, one for IgG2a, and one for IgGI and IgG2b (5-8) . However,
the two murine FcyR differ from the rat FcyR in their trypsin sensitivity in that the
mouse IgG2a FcR is trypsin sensitive and the IgGI/IgG2b FcR is resistant. In addition
to the FcyR, FcER seem to be a characteristic of Mo and the related blood monocytes.
Mouse macrophagelike cells P388D1 formed specific rosettes with Eo' coated with rat
IgE, and recent experiments performed in our laboratory showed that the majority of
mouse AMO form rosettes with mouse IgE-coated indicator erythrocyte, and bind
radiolabeled mouse IgE (unpublished observations). Similarly, human U937 macro-
phagelike cells form IgE rosettes and bind radiolabeled human IgE (27) . We have
previously shown that human peripheral blood monocytes form IgE rosettes and lyse
specifically IgE-coated target cells (28) . It appears from these experiments that FcyR
and FcER are the major FcR on Mq) and monocytes.
By using a rosette assay with Ed coated with rat myeloma proteins, we could not
demonstrate FcR for IgM, IgA, IgD, or IgG2c on rat Mq). Although other investigators
similarly failed to demonstrate FcR for IgM and IgA on Mo (5, 8, 29-31), Haegert
(32) reported that neuraminidase-treated human and rabbit monocytes form IgM
rosettes. Therefore, we treated the rat Mo with neuraminidase and, in addition,
cultured them in media free of rat serum to allow elution of in vivo FcR bound IgM,
which appears to inhibit IgM rosette formation on T lymphocytes (33) . However,
after such treatment, rat Mo did not form IgM rosettes. Fanger et al. (34) showed
that human monocytes have IgA FcR by formation of rosettes with Eo sensitized with
rabbit secretory IgA anti-Eo antibodies. However, by using either rabbit IgM anti-Eo
or mouse MOPC315 IgA anti-DNP-sensitized erythrocytes, we still could not dem-
onstrate IgM or IgA FcR on the rat Mo. Recently, Diamond and Yelton (35)
characterized a new FcR specific for IgG3 on mouse Mo using sheep erythrocytes
sensitized with a mouse IgG3 hybridoma anti-Eo antibody. In contrast to IgG2a and
IgGl/IgG2b rosettes, the IgG3 rosettes were inhibited only with aggregated but not
monomeric IgG3. Rat Mo may have FcR for IgG2c, IgM, and IgA, but FcR were not
detected by our method because they may be few in number and/or of low affinity.
Binding studies of radiolabeled monomeric and aggregated Ig of these classes will be
necessary to address this possibility.G. BOLTZ-NITULESCU, H . BAZIN, AND H . L. SPIEGELBERG
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Rat IgE inhibited IgG1/IgG2b rosettes as much as did IgGI and IgG2b, but it did
not inhibit IgG2a rosettes . This inhibition could not be explained by IgGI and IgG2b
contamination of the IgE preparations . First, IgG was not detected by gel diffusion
methods and SDS-PAGE . Second, no evidence for IgG aggregates in the IgE prepa-
ration was obtained because both top and bottom portions of ultracentrifuged IgE
preparations inhibited IgGl/IgG2b rosettes equally . Finally, heating the IgE at 56 °C,
which induces irreversible conformational changes in the CE3 and CE4 regions of the
IgE Fc fragments (26), destroyed the ability of IgE to inhibit not only IgE but also
IgGl/IgG2b rosettes . In contrast, heating rat IgG at 56°C did not destroy the ability
of IgG to react with FcyR (13) . A cross-reaction of rat IgE with FcyR was also
observed by Yodoi and Ishizaka (36) on rat lymphocytes and by Segal et al . (37) on
rat basophilic leukemia cells . These investigators used rabbit IgG to detect FcyR,
which, based on the present experiments, presumably reacted only with IgGl/IgG2b
FcR . The cross-inhibition by rat IgE of IgGl/IgG2b rosettes seems to be unique to
the rat cells. Mouse Mo formed rosettes with rat IgGI and IgG2b, but rat IgE failed
to inhibit these or any other IgG rosettes . Similarly, human IgE did not inhibit IgG
rosettes on human Mo . It could not be determined from our studies whether IgE
reacted with the IgGl/IgG2b FcR or whether binding of IgE to the FCER inhibited
IgGl/IgG2b rosettes by steric hindrance . However, rat IgE inhibits IgG rosettes on
FCER negative lymphocytes (36), suggesting that rat IgE may bind to the rat IgGl/
IgG2 FcR . The biological significance of IgE interaction with IgGl/IgG2b receptors
is unknown . Yodoi and Ishizaka (36, 38) suggested that IgE reacting with FcyR may
provide a signal to the lymphocytes to switch from expressingFcyR to FCER . However,
because rat IgE failed to cross-react with FcyR on mouse Mo, and human IgE failed
to cross-react with FcyR on human Mo and lymphocytes (23), further evidence is
necessary to determine whether the interaction of IgE with FcyR induces FCER .
Like mouse Mo, rat Mo presumably possess different membrane proteins or protein
complexes that form the FcyR . The differences in trypsin sensitivity of the rat and
mouse FcyR, the occurrence of mutant mouse Mo cell lines having only FcyR for
IgG2a (7, 8), and the demonstration of two different peptides binding either murine
IgG2a or IgGl/IgG2b (10), suggest structurally different Fcy receptors, at least on the
intact cell. However, recent experiments reported by Mellmann and Unkeless (39)
and by Schneider et al . (40) have demonstrated a lack ofIgG subclass specificity of
the solubilized FcyR . The FcyR may be composed ofdifferent peptides that rearrange
upon solubilization of the cell membrane, thus altering the specificity of the FcR .
Isolation and physicochemical characterization of the peptides binding Fc fragments
will be necessary to determine structural differences among various FcR on macro-
phages .
Established functions of FcR on M(p are attachment, ingestion, and lysis of IgG-
coated particles . Whether IgGI/IgG2b and IgG2a FcR each mediate special functions
is unresolved . Walker (41) reported that IgG2b FcR on murine Mo mediate killing of
antibody-coated target cells, whereas IgG2a FcR do not . In contrast, Ralph et al . (42)
showed that antibodies of all murine IgG subclasses mediate phagocytosis and
antibody-dependent cellular cytotoxicity . Moreover, FCER on rat M(A mediate the
killing of Schistosoma mansoni schistosomules (43, 44) and secretion of a-glucuronidase
(45) . Mouse Mo release slow reacting substances of anaphylaxis (SRS-A) after
incubation with ionophore A23187 (46, 47) or in response to phagocytic stimuli (48,382
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49) . If the interaction of IgE immune complexes with IgE FcR on MO and on
monocytes can induce SRS-A release, it may establish a previously unrecognized
pathway for the induction of anaphylactic reactions.
Summary
To characterize the Fc receptors on rat alveolar and peritoneal macrophages (MO),
we analyzed their ability to form rosettes with fixed ox erythrocytes (Eo) coated with
myeloma proteins of all rat Ig classes and with fresh erythrocytes (Eo) sensitized with
rat IgGI and IgG2, rabbit IgG and IgM, and mouse IgA antibodies. The MO formed
rosettes with Eo' coated with rat myeloma proteins of classes IgGl, IgG2a, IgG2b,
and IgE but not IgG2c, IgA, IgM, and IgD. Rat Mo also formed rosettes with Eo'
coated with human IgGl, IgG3, IgG4, mouse IgGl, IgG2a, IgG2b, and rabbit IgG.
Furthermore, rat MqS formed rosettes with Eo sensitized with rat IgGI, IgG2, or rabbit
IgG antibodies but not with Eo sensitized with rabbit IgM or mouse IgA antibodies.
Trypsin treatment of rat Mo abolished IgGl/IgG2b and IgE but not IgG2a rosettes.
The IgG2a and IgE rosettes were Ig class specific because they were inhibited only
by rat IgG2a and rat IgE, respectively. In contrast, IgGI and IgG2b rosettes were
inhibited equally by IgGI and IgG2b. Heterologous IgG inhibited IgGl/IgG2b but
not IgG2a rosettes. Rat IgE inhibited rat IgGI, IgG2b, and heterologous IgG rosette
formation on rat Mo. Although Eo' coated with rat IgE formed rosettes with mouse
P388D1 macrophagelike cells, rat IgE did not inhibit IgG rosettes on these cells.
Similarly, Eo' coated with human IgE formed rosettes with human U937 macrophage-
like cells, but human IgE did not inhibit IgG rosettes on these cells.
The results indicate that rat Mtp have at least three distinct Fc receptors: one is
specific for rat IgG2a and is trypsin resistant; a second is specific for rat IgE and is
trypsin sensitive; and a third reacts with rat IgG l rat IgG2b, and heterologous IgG
and is trypsin sensitive. Rat IgE inhibited IgGI/IgG2b rosettes unidirectionally and
uniquely on rat Mo.
Receivedfor publication 6 April 1981.
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